Remission of Merkel cell tumor after somatostatin analog treatment | Zendy

Mahmoud Fakiha | Zendy; Paule Letertre | Zendy; J.-P. Vuillez | Zendy; J. Lebeau | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Remission of Merkel cell tumor after somatostatin analog treatment

Author(s) -

Mahmoud Fakiha,

Paule Letertre,

J.-P. Vuillez,

J. Lebeau

Publication year - 2010

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.73352

Subject(s) - lanreotide , merkel cell carcinoma , somatostatin , medicine , merkel cell , oncology , somatostatin analogue , cancer research , octreotide , carcinoma , hormone , growth hormone , acromegaly

We recently treated one patient presenting with a disseminated non-operable Merkel cell carcinoma (MCC) by lanreotide (somatostatin analog), with a complete remission of the disease and a follow up of 17 months. We present in this paper a case report with a review of the utilization of somatostatin analogues in the treatment of MCC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research